Clinical Trials Directory

Trials / Completed

CompletedNCT05330195

Bicycle Ergometer Training in Duchenne Muscular Dystrophy

The Effects of Bicycle Training on Gait and Balance in Children With Duchenne Muscular Dystrophy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Hacettepe University · Academic / Other
Sex
Male
Age
5 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The progressive muscle weakness and contractures of the patients adversely affect their gait and balance. It is known that the disorder of the patients' balance and gait affects their functional capacity. The aim of this study is to examine the effects of bicycle ergometer training on gait and balance in children with Duchenne Muscular Dystrophy. Twenty-four children with DMD included in the study will be divided into two groups as home program and home program+bicycle ergometer training with block randomization method. Home program including stretching, respiratory, range of motion, posture and mild resistance exercise with body weight will be asked to apply 3-5 days a week for 12 weeks, aerobic training will be performed 3 days a week for 12 weeks at 60% of their maximum hearth rate with 40 minutes total duration consisting of 5 min warm up and 5 min cool down period. Gait and balance were evaluated with GAITrite and Bertec Balance Check Screener, successively. Assessments will be applied at pre-training and after 12 weeks of training.

Conditions

Interventions

TypeNameDescription
OTHERBicycle Ergometer TrainingBicycle ergometer training will be performed 3 days a week for 12 weeks at 60% of their maximum hearth rate with 40 minutes total duration consisting of 5 min warm up and 5 min cool down period to children in treatment group.
OTHERHome-based exercise groupChildren will be given a home program including stretching, breathing, normal joint movement, body weight and mildly resistant exercises, and children will be asked to do these for 3 to 5 days a week.

Timeline

Start date
2022-04-18
Primary completion
2023-02-28
Completion
2023-05-25
First posted
2022-04-15
Last updated
2023-10-11

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05330195. Inclusion in this directory is not an endorsement.